Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy [PDF]
Histone deacetylases (HDACs) are pivotal epigenetic regulators that control gene expression, cell proliferation, and differentiation, and their dysregulation is closely associated with the onset and progression of multiple cancers.
Mohammed Hawash
doaj +3 more sources
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective [PDF]
Histone deacetylases (HDACs) are epigenetic enzymes that play a central role in gene regulation and are sensitive to the metabolic state of the cell.
Jacob King +2 more
doaj +4 more sources
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases
Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective therapeutic approach for reversing epigenetic alteration in several diseases.
Geetha Shanmugam +2 more
doaj +2 more sources
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunotherapy resistance is a major challenge for B-cell lymphoma treatment.
Xiaoguang Wang +5 more
doaj +2 more sources
Advancements in Hydrazide-Based HDAC Inhibitors: A Review of Recent Developments and Therapeutic Potential. [PDF]
Histone deacetylase (HDAC) impairment is strongly related to various cancers as well as neurodegenerative and inflammatory diseases. Considering HDACs’ crucial role as drug targets, over the past decade, the development of HDAC inhibitors (HDACi) has ...
Raucci A, Zwergel C, Valente S, Mai A.
europepmc +2 more sources
Differential effects of HDAC inhibitors in the Rho I255d mouse model for autosomal dominant retinitis pigmentosa [PDF]
Retinitis Pigmentosa (RP) is an inherited neurodegenerative disease which leads to loss of retinal photoreceptors and blindness. Histone deacetylases (HDAC) were previously found to be involved in photoreceptor cell death, and HDAC inhibitors have shown ...
Yu Zhu +3 more
doaj +2 more sources
Recent Update of HDAC Inhibitors in Lymphoma
Modulating epigenetic modification has been recognized for over a decade as an effective therapeutic approach to cancer and many studies of histone deacetylase (HDAC), one of the best known epigenetic modulators, have been published.
I-Chung Chen +2 more
doaj +2 more sources
PARP inhibitors and HDAC inhibitors have been approved for the clinical treatment of malignancies, but acquired resistance of or limited effects on solid tumors with a single agent remain as challenges.
Qingyun Zhu +13 more
doaj +2 more sources
Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer
Novel treatment regimens are required for castration-resistant prostate cancers (CRPCs) that become unresponsive to standard treatments, such as docetaxel and enzalutamide.
Zohaib Rana +3 more
doaj +2 more sources
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies [PDF]
Histone deacetylation represents a significant epigenetic mechanism that involves the removal of acetyl groups from histones, subsequently influencing gene transcription.
Wanli Zhang +7 more
doaj +2 more sources

